Determination of MDMA and its Metabolites in Blood and Urine by Gas ChromatographyMass Spectrometry and Analysis of Enantiomers by Capillary Electrophoresis
Authors: Segura J.1; Pizarro N.2; Camí J.1; Ortuño J.2; de la Torre R.3; Farré M.4; Hernández-López C.2; Pujadas M.2; Llebaria A.5; Joglar J.5; Roset P.N.2; Mas M.2
Source: Journal of Analytical Toxicology, Volume 26, Number 3, April 2002 , pp. 157-165(9)
Publisher: Preston Publications
Abstract:
A gas chromatographymass spectrometry (GCMS) method was used for the simultaneous quantitation of 3,4-methylenedioxymethamphetamine (MDMA) and the 3,4-methylenedioxyamphetamine (MDA), 4-hydroxy-3-methoxymethamphetamine (HMMA), and 4-hydroxy-3-methoxyamphetamine (HMA) metabolites in plasma and urine samples after the administration of 100 mg MDMA to healthy volunteers. Samples were hydrolyzed prior to a solid-phase extraction with Bond Elut Certify ® columns. Analytes were eluted with ethyl acetate (2% ammonium hydroxide) and analyzed as their trifluoroacyl derivatives. Linear calibration curves were obtained at plasma and urine concentration ranges of 25400 ng/mL and 2502000 ng/mL for MDMA and HMMA, and of 2.540 ng/mL and 1001000 ng/mL for MDA and HMA. Following the same urine preparation procedure but without the derivatization step, a capillary electrophoresis (CE) method for enantiomerical resolution of compounds was developed using (2-hydroxy)propyl-
-cyclodextrin at two different concentrations (10 and 50mM in 50mM H3PO4, pH 2.5) as chiral selector. Calibration curves for the CE method were prepared with the corresponding racemic mixture and were linear between 125 and 2000 ng/mL, 50 and 1000 ng/mL, and 125 and 1500 ng/mL for each enantiomer of MDMA, MDA, and HMMA, respectively. Stereoselective disposition of MDMA and MDA was confirmed. HMMA disposition seems to be in apparent contradiction with MDMA findings as the enantiomer ratio is close to 1 and constant over the time.
Language: English
Document Type:
Affiliations: 1: Pharmacology Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Universitat Pompeu Fabra 2: Pharmacology Research Unit, Institut Municipal d'Investigació Mèdica (IMIM) 3: Pharmacology Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Universitat Autònoma, Universitat Pompeu Fabra, Correspondence Address: Pharmacology Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Doctor Aiguader 80, E-08003 Barcelona, Spain. E-mail: rtorre@imim.es 4: Pharmacology Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Universitat Autònoma 5: Department of Biological Organic Chemistry, Institut de Investigacions Químiques i Ambientals, E-08003 Barcelona, Spain

Click here for Page Help